CA30668-1A - 0x0000000000004A35
Healthy Males & Females
Anti
* Stipend may pay up to reflected amount.
Study Details
Study Number: CA30668
Group Number: 1A
Study Requirement: Healthy Normal Male and Female
Stipend: up to £
1,375
Study Criteria
Age: 18 - 0
BMI: 0 - 0
Weight Restriction: minimum weight 0 lbs
Study Information
Indication: This investigational medication is being developed to treat non-cystic fibrosis bronchiectasis.
Route of Administration: Inhalation
Blood Draws: 10
Study Schedule
Schedule Type: Short stays with returns
Study Length: One - 3 Night Stay & 2 Returns
Screening Dates:
| Event Day | Event Date | Site |
|---|---|---|
| No search results |
Doctor Exam Dates:
| Event Day | Event Date | Site |
|---|---|---|
| No search results |
Study Dates:
| Event Type | Start Day | Start Date | End Day | End Date | Phase | Site |
|---|---|---|---|---|---|---|
| No search results |
